UNI-EN 15:Online meeting with investors and exercising the right to vote by correspondence at the General Meeting of Shareholders convened on June 5, 2020
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 15 | / | 2020 | |||||||
| Date of issue: | 2020-05-26 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Online meeting with investors and exercising the right to vote by correspondence at the General Meeting of Shareholders convened on June 5, 2020 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| „Sopharma“ AD invites all shareholders of the Company to exercise their voting right on the announced agenda items of the Annual General Meeting convened for 5 June 2020 through correspondence. In an effort to preserve the normal operation of all the bodies of “Sopharma” AD and at the same time not to jeopardize the health of the interested parties in the conditions of a pandemic, the Board of Directors provide an opportunity for shareholders to exercise their voting rights in advance. On the day of the General Meeting the Company will hold an online meeting with Ognyan Donev, PhD, Executive Director and Chairman of the Board of Directors of “Sopharma” AD, Dimitar Dimitrov, Executive Director of “Sopharma Trading” AD and Alexander Hristov, Executive Director of “Doverie Obedinen Holding” AD. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_2020_AGM_corr_invmeet_espi.pdf 3JR_2020_AGM_corr_invmeet_espi.pdf | Online meeting with investors and exercising the right to vote by correspondence at the General Meeting of Shareholders convened on June 5, 2020 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2020-05-26 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 15.1 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
